Core Viewpoint - The company, Qingdao Sanbai Shuo Health Technology Co., Ltd., has disclosed its 2025 semi-annual report and related resolutions from board meetings, indicating no changes in major shareholder structure and outlining future plans for shareholder returns and governance adjustments [1][8][14]. Company Basic Information - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period [5][6]. - The board of directors and the supervisory board have both approved the semi-annual report and its summary, with unanimous votes in favor [8][22]. Financial Data and Fund Management - The company raised a total of approximately RMB 680.74 million through its initial public offering, with a net amount of RMB 610.65 million after deducting issuance costs [50]. - As of June 30, 2025, the balance of the special account for raised funds was RMB 2.30 million, with an additional RMB 466 million in cash management accounts, totaling RMB 468.30 million [53]. - The company has utilized RMB 141.43 million of the raised funds for various projects, with plans to use up to RMB 500 million of temporarily idle funds for cash management [54][56]. Governance and Structural Changes - The company has decided to abolish the supervisory board, transferring its responsibilities to the audit committee of the board of directors, and has proposed amendments to its articles of association accordingly [10][23]. - A new three-year shareholder return plan for 2025-2027 has been approved, which will be submitted for shareholder meeting approval [14][26]. Upcoming Shareholder Meeting - The company plans to hold its first extraordinary general meeting of 2025 on September 9, 2025, to discuss various proposals, including the amendments to the articles of association and the shareholder return plan [18][30].

Group 1 - The company has opened a temporary special account for idle raised funds to supplement working capital, with a limit of up to RMB 200 million, for a period not exceeding 12 months [3][4][12] - The total amount raised from the non-public offering was RMB 695.58 million, with a net amount of RMB 684.93 million after deducting issuance costs [2] - The company has signed a tripartite supervision agreement with the sponsor and the bank to ensure proper management and usage of the raised funds [4][5][6] Group 2 - The company has utilized idle raised funds for cash management, with a maximum of RMB 450 million approved for investment in financial products [12][16] - The company has redeemed RMB 50 million in financial products, earning a cash management return of RMB 257,952.99, which has been fully deposited into the special account [13][16] - The company has invested RMB 30 million in a structured deposit with a projected annual yield of 1.45%, ensuring that the investment does not affect the normal operation of the fundraising projects [14][16]

Group 1 - The company has approved the termination of the "Commercial Professional Pump Industrialization Project" and plans to permanently supplement the remaining raised funds into working capital [30][38][41] - The company raised a total of RMB 517.60 million through a non-public offering of shares, with a net amount of RMB 512.10 million after deducting issuance costs [14][32] - As of June 30, 2025, the balance of the raised funds in the special account was RMB 2.78 million, and the company temporarily supplemented working capital with RMB 35 million from idle raised funds [15][19] Group 2 - The company will hold its first temporary shareholders' meeting of 2025 on September 8, 2025, to discuss the approved resolutions [46][47] - The company will conduct a half-year performance briefing on September 2, 2025, to communicate with investors and address their concerns [58][61] - The company has established a dual supply chain to ensure stable supply to the North American market, with an overseas production base set up in Thailand [38][39]

Core Viewpoint - The company has released its 2025 semi-annual report, detailing its financial performance and management of raised funds, while ensuring compliance with relevant regulations and transparency in operations [1][5][20]. Group 1: Company Overview - Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is engaged in the development and production of vaccines and biological products [2]. - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period [2]. Group 2: Financial Data - The total amount raised from a non-public offering in June 2022 was approximately RMB 349,999.99 million, with a net amount of RMB 346,015.57 million after deducting related expenses [20]. - As of June 30, 2025, the remaining balance of raised funds was RMB 150,940.25 million, including RMB 23,025.20 million in dedicated accounts and RMB 127,915.05 million in principal-protected financial products [21][22]. Group 3: Fund Management - The company has established a dedicated fund management system, ensuring that raised funds are stored in special accounts and managed in compliance with regulations [23][24]. - The company has signed tripartite supervision agreements with banks and its sponsor to ensure the proper use of raised funds [24][25]. Group 4: Fund Utilization - In the first half of 2025, the company directly invested RMB 19,132.35 million into projects funded by the raised capital [21]. - The company has not terminated any new fundraising investment projects during the reporting period [30]. Group 5: Impairment Provisions - The company has recognized a total impairment provision of RMB 8,085.62 million for the first half of 2025, which includes credit impairment losses of RMB 5,743 million and inventory impairment losses of RMB 2,342.62 million [42][44]. - The increase in credit impairment losses is attributed to delayed payments from local disease control centers due to financial constraints [41]. Group 6: Investor Communication - The company plans to hold a semi-annual performance briefing on September 2, 2025, to address investor inquiries and provide insights into its financial results [35][36].

Group 1 - The company has completed its initial public offering (IPO) by issuing 22 million shares at a price of RMB 38.85 per share, raising a total of RMB 854.7 million, with a net amount of RMB 758.56 million after deducting fees [3][4] - The company also issued convertible bonds with a total face value of RMB 950 million, raising a net amount of RMB 939.93 million after fees [4] - As of June 30, 2025, the company has used RMB 100 million from the IPO funds to permanently supplement working capital [12] Group 2 - The company has established a management method for the raised funds to ensure compliance with regulations and protect investor rights [3][4] - The company has signed tripartite supervision agreements with banks for the management of raised funds, ensuring proper oversight [5][6] - As of June 30, 2025, the company has not used any idle IPO funds for cash management [15] Group 3 - The company has not experienced any delays in the investment projects funded by the IPO or convertible bond proceeds during the reporting period [8][9] - The actual investment amounts for the industrial robot production project and the R&D center exceeded the initial commitments, with differences funded by interest income [29] - The company has not made any changes to the investment projects or transferred funds to external parties [25] Group 4 - The company has revised its governance system to align with the latest legal and regulatory requirements [30] - The company will participate in a collective performance briefing for the new energy industry on September 3, 2025, to discuss its half-year results [32][36] - Investors can submit questions for the briefing in advance, and the company will address common concerns during the session [34][36]

Group 1 - The company has issued convertible bonds amounting to RMB 117,500 million, with a net amount of RMB 116,298.33 million after deducting issuance costs [4][15]. - The funds raised have been fully deposited into a special account established for this purpose, and the company has signed tripartite supervision agreements with relevant parties [5][6]. - As of June 30, 2025, the balance in the special account includes RMB 10,000 million in unexpired financial products [5][6]. Group 2 - The company has not experienced any significant changes in its operational situation during the reporting period [13]. - There have been no abnormal situations regarding the investment projects funded by the raised capital [7]. - The company has not used idle raised funds to temporarily supplement working capital during the first half of 2025 [9][10]. Group 3 - The company has approved the use of RMB 77,606.10 million of the raised funds to replace self-raised funds previously invested in projects and to cover issuance costs [8]. - The company has also approved the use of up to RMB 400 million of idle raised funds for cash management, with a balance of RMB 100 million utilized for this purpose as of June 30, 2025 [9][10]. - There are no instances of using excess raised funds for new projects or to repay bank loans during the reporting period [10][11]. Group 4 - The company has decided to cancel its supervisory board, transferring its responsibilities to the audit committee of the board of directors [24][45]. - The registered capital of the company has increased from RMB 113,834,777 to RMB 148,943,529 due to the completion of stock incentive plans and capital increases [25][48]. - The company has revised its articles of association to align with new regulatory requirements and improve corporate governance [49][50].

公司代码：603138 公司简称：海量数据 第一节 重要提示 1.1本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规 划，投资者应当到www.sse.com.cn网站仔细阅读半年度报告全文。 1.2本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性，不存在虚假 记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 1.3董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无。 登录新浪财经APP 搜索【信披】查看更多考评等级 第二节 公司基本情况 2.1公司简介 ■ 2.2主要财务数据 单位：元 币种：人民币 ■ 2.3前10名股东持股情况表 单位: 股 ■ 2.4截至报告期末的优先股股东总数、前10名优先股股东情况表 □适用 √不适用 2025年半年度募集资金存放 2.5控股股东或实际控制人变更情况 □适用 √不适用 2.6在半年度报告批准报出日存续的债券情况 □适用 √不适用 第三节 重要事项 公司应当根据重要性原则，说明报告期内公司经营情况的重大变化，以及报告期内发生的对公司经营情 况有重大影响和预计未来会有重大影响的事项 □适用 √ ...

Fundraising Overview - The company has received approval from the China Securities Regulatory Commission to issue 86,546,026 A-shares at a price of 12.71 yuan per share, raising a total of approximately 1.1 billion yuan, with a net amount of about 1.09 billion yuan after deducting issuance costs [1][2] Fund Management and Supervision - A tripartite supervision agreement for the management of the raised funds has been signed with relevant financial institutions to ensure compliance with regulations and protect investor rights [1][3] - As of August 8, 2025, the balance in the dedicated account for the raised funds is approximately 1,094.15 million yuan, which is exclusively for the use of the funds raised from the A-share issuance [3][4] Responsibilities and Compliance - The company is required to comply with various laws and regulations regarding fund management and usage, and must maintain detailed records of all fund expenditures [4][5] - The sponsoring institution is responsible for supervising the use of the raised funds and must conduct regular checks on the dedicated account [4][6] Reporting and Accountability - The company must provide monthly account statements to the sponsoring institution and notify them of any significant withdrawals exceeding 20% of the net raised funds [5][6] - Failure to comply with the reporting requirements may result in the termination of the supervision agreement and the need to establish a new dedicated fund account [6]

Core Points - The company, Tianji New Energy Technology Co., Ltd., has released its 2025 semi-annual report, which includes financial results and future development plans [1] - The board of directors and the supervisory board have unanimously approved the semi-annual report and the special report on the use of raised funds [10][20] - The company has not distributed cash dividends or bonus shares during the reporting period [3] Group 1: Company Overview - Tianji New Energy Technology Co., Ltd. is engaged in the production and development of new energy technologies [2] - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period [5][6] Group 2: Financial Data and Fund Management - The company raised a total of approximately 895 million RMB through the issuance of 96,030,038 shares at a price of 9.32 RMB per share [22] - As of June 30, 2025, the company has utilized approximately 694 million RMB of the raised funds, leaving a balance of about 182 million RMB [23] - The company has established special accounts for the management of raised funds in various banks to ensure proper usage and compliance with regulations [24][25] Group 3: Fund Usage and Investment Projects - The company has pre-invested approximately 390 million RMB in projects using self-raised funds, which have been replaced with raised funds as approved by the board [27] - The company has temporarily used 114 million RMB of idle raised funds to supplement working capital, with a usage period not exceeding 12 months [29] - The company has also engaged in cash management with idle raised funds, amounting to 339 million RMB, with a total return of approximately 2.43 million RMB from cash management products [29] Group 4: Project Adjustments - The company has postponed the completion date for a lithium salt project from December 2024 to December 2025 due to market conditions [30] - The company has added a new implementation entity and location for the lithium salt project, which will not affect the project's content or funding usage [31]

Group 1 - The company plans to distribute a cash dividend of RMB 0.02 per share (including tax) based on the total share capital on the record date for the profit distribution [3][4][5] - The total amount of cash dividends to be distributed is estimated to be RMB 20,433,607.06 (including tax), which represents 33.89% of the net profit attributable to shareholders for the corresponding period [4][5][6] - The profit distribution plan is subject to approval by the company's shareholders' meeting [5][6] Group 2 - The company held a board meeting on August 20, 2025, where the cash dividend proposal was approved, aligning with the company's profit distribution policy and shareholder return plan [6][8] - The audit committee of the board also approved the cash dividend proposal, stating it complies with relevant regulations and reflects the company's commitment to reasonable returns for investors [8][9] - Independent directors expressed that the profit distribution plan aligns with the company's long-term development needs and does not harm the interests of shareholders, especially minority shareholders [9] Group 3 - The company has issued a report on the use of raised funds, detailing the actual amount raised and its allocation [31][32] - The total amount raised from the issuance of convertible bonds was RMB 510 million, with a net amount of RMB 501.73 million after deducting fees [31][32] - As of June 30, 2025, the company has utilized RMB 442.50 million of the raised funds, with a remaining balance of RMB 68.83 million [33][34] Group 4 - The company has established a special account for the management of raised funds, ensuring compliance with relevant regulations [34][36] - The company signed a tripartite supervision agreement with banks to manage the raised funds, ensuring proper oversight [36][37] - The company has not used idle raised funds for temporary working capital, maintaining the integrity of the investment projects [46][49] Group 5 - The company plans to increase its wholly-owned subsidiary, Xuanhan Zhengyuan Microfiber Co., Ltd., by converting debt into equity, amounting to RMB 20.99 million [60][61] - This investment is part of the company's ongoing project to produce high-performance ultra-fine glass fiber, which has already reached its intended operational state [60][61] - The board has approved this investment, which does not require shareholder approval as it falls within the board's authority [61][62]